ERBB2 and breast cancer: Herein we sought to determine alterations of Ca2+-signalling proteins in the context of trastuzumab-resistance using HER2-positive SKBR3 breast cancer cell lines as models of intrinsic (no previous trastuzumab exposure) and acquired resistance.